Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

0.8

Margin Of Safety %

Put/Call OI Ratio

0.86

EPS Next Q Diff

0.3

EPS Last/This Y

1.06

EPS This/Next Y

0.87

Price

238.5

Target Price

285.08

Analyst Recom

1.55

Performance Q

-11.07

Relative Volume

0.97

Beta

0.84

Ticker: DHR




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2024-12-19DHR226.170.753.16127643
2024-12-20DHR228.610.752.38129135
2024-12-23DHR229.250.840.90106829
2024-12-24DHR230.750.840.51108154
2024-12-26DHR231.370.830.96108597
2024-12-27DHR231.130.830.96108973
2024-12-30DHR229.670.811.03107120
2024-12-31DHR229.570.801.47108028
2025-01-02DHR229.90.802.05108580
2025-01-03DHR234.850.800.71108428
2025-01-06DHR238.310.801.39108673
2025-01-07DHR239.180.822.26110910
2025-01-08DHR238.080.840.47112714
2025-01-09DHR238.090.840.55112714
2025-01-10DHR235.060.840.55114282
2025-01-13DHR239.930.840.66113032
2025-01-14DHR237.630.830.90114307
2025-01-15DHR237.980.841.83114692
2025-01-16DHR241.90.864.13117330
2025-01-17DHR238.360.860.52117589
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2024-12-19DHR226.112.81720.47.50
2024-12-20DHR228.592.81844.27.50
2024-12-23DHR229.162.91795.17.50
2024-12-24DHR230.752.91821.17.50
2024-12-26DHR231.282.91792.87.50
2024-12-27DHR231.082.91773.67.50
2024-12-30DHR229.702.91749.07.50
2024-12-31DHR229.642.91775.37.50
2025-01-02DHR229.872.91794.57.50
2025-01-03DHR234.892.91920.97.50
2025-01-06DHR238.212.91866.57.50
2025-01-07DHR239.162.91803.57.50
2025-01-08DHR238.092.91753.07.50
2025-01-09DHR238.092.91778.97.50
2025-01-10DHR235.042.91700.57.50
2025-01-13DHR239.932.91905.17.50
2025-01-14DHR237.672.91722.57.50
2025-01-15DHR238.072.91790.47.50
2025-01-16DHR241.952.91881.17.50
2025-01-17DHR238.502.91692.87.50
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2024-12-19DHR-0.30-1.840.78
2024-12-20DHR-0.30-1.840.78
2024-12-23DHR-0.30-1.870.78
2024-12-24DHR-0.30-1.870.78
2024-12-26DHR-0.30-1.870.83
2024-12-27DHR-0.30-1.870.83
2024-12-30DHR-0.30-2.270.83
2024-12-31DHR-0.30-2.270.83
2025-01-02DHR-0.30-2.270.83
2025-01-03DHR-0.30-2.270.83
2025-01-06DHR-0.30-2.280.83
2025-01-07DHR-0.30-2.280.83
2025-01-08DHR-0.30-2.280.83
2025-01-09DHR-0.30-2.280.83
2025-01-10DHR-0.30-2.280.83
2025-01-13DHR-0.30-1.750.80
2025-01-14DHR-0.30-1.750.80
2025-01-15DHR-0.30-1.750.80
2025-01-16DHR-0.30-1.750.80
2025-01-17DHR-0.30-1.750.80
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

1.71

Avg. EPS Est. Current Quarter

2.15

Avg. EPS Est. Next Quarter

2.01

Insider Transactions

-0.3

Institutional Transactions

-1.75

Beta

0.84

Average Sales Estimate Current Quarter

6391

Average Sales Estimate Next Quarter

6020

Fair Value

238.52

Quality Score

88

Growth Score

76

Sentiment Score

80

Actual DrawDown %

19.4

Max Drawdown 5-Year %

-36.6

Target Price

285.08

P/E

45.46

Forward P/E

29.02

PEG

6.11

P/S

7.25

P/B

3.36

P/Free Cash Flow

34.36

EPS

5.24

Average EPS Est. Cur. Y​

7.5

EPS Next Y. (Est.)

8.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

16.39

Relative Volume

0.97

Return on Equity vs Sector %

-11.5

Return on Equity vs Industry %

-2.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

1692.8
Danaher Corporation
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 61000
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.
stock quote shares DHR – Danaher Corporation Stock Price stock today
news today DHR – Danaher Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch DHR – Danaher Corporation yahoo finance google finance
stock history DHR – Danaher Corporation invest stock market
stock prices DHR premarket after hours
ticker DHR fair value insiders trading